500mg Dalbonova Dalbavancin Inection
Dalbonova 500 mg Injection contains Dalbavancin, a long-acting lipoglycopeptide antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susce...
In Stock
500mg Dalbonova Dalbavancin Inection
Dalbonova 500 mg Injection contains Dalbavancin, a long-acting lipoglycopeptide antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Dalbavancin is administered via intravenous infusion, often as a single dose or two doses one week apart, providing convenient treatment with prolonged activity. Common side effects may include nausea, diarrhea, headache, and infusion-related reactions. Use under strict medical supervision with monitoring for allergic reactions and kidney function
| Strength | 500 mg |
| Brand Name | DALVABANCIN |
| Packaging Size | 1 vial |
| Treatment | Use under strict medical supervision with monitoring for allergic reactions and kidney function |
